Investigation of cardiotoxicity by dipeptidyl-peptidase-4 inhibitors in a human cardiomyocyte cell line as well as in samples from chronic heart failure patients
Event:
Frontiers in CardioVascular Biomedicine 2022
Topic:
Heart Failure
Session:
Poster Session 1